Analysis of information sources in references of the Wikipedia article "2022~2023년 엠폭스 유행" in Korean language version.
Bavarian Nordic, the biotech company that makes the vaccine, has announced a $119 million order placed by the U.S., with an option to buy $180 million more, for delivery in 2023 and 2024. Should the second option be exercised, it would work out to approximately 13 million doses.
Bavarian Nordic, the biotech company that makes the vaccine, has announced a $119 million order placed by the U.S., with an option to buy $180 million more, for delivery in 2023 and 2024. Should the second option be exercised, it would work out to approximately 13 million doses.